ClinicalTrials.gov
public full text
Public Domain
Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma
In this trial the investigators want to combine chemotherapy with immunotherapy by giving the patients Temozolomide, before vaccination. The investigators have also included hTERT and survivin mRNA in the vaccine. Finally, the investigators want to introduce ex vivo T cell expansion after lymphodepletion for the patients who show an immune response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma#18694
- Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma#1323691
- Vaccine Therapy in Treating Patients With Metastatic Melanoma#441966
- Vaccine Therapy in Treating Patients With Metastatic Melanoma#366641
- Vaccine Therapy in Treating Patients With Metastatic Melanoma#127689
Record · ID 1184999
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive